Literature DB >> 10833312

Interleukin-1 promotes expression and phosphorylation of neurofilament and tau proteins in vivo.

J G Sheng1, S G Zhu, R A Jones, W S Griffin, R E Mrak.   

Abstract

Slow-release, IL-1-impregnated pellets implanted in rat cerebral cortex to simulate chronic overexpression of IL-1 significantly increased relative tissue levels of tau mRNA and of tau immunoreactivity in neuronal cell bodies and in swollen dystrophic neurites that also overexpressed phosphorylated and nonphosphorylated neurofilament epitopes. In addition, rats with IL-1-impregnated pellets, but not control rats or those with sham pellets, showed focal immunoreactivity for hyperphosphorylated tau epitopes present in paired helical filaments. Our results are consistent with an important driving role for IL-1 in the pathogenesis of Alzheimer-type neuronal and neuritic changes. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10833312      PMCID: PMC3886634          DOI: 10.1006/exnr.2000.7393

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  18 in total

Review 1.  Neurodegenerative disorders with extensive tau pathology: a comparative study and review.

Authors:  M B Feany; D W Dickson
Journal:  Ann Neurol       Date:  1996-08       Impact factor: 10.422

2.  Tau mRNA isoforms following sciatic nerve axotomy with and without regeneration.

Authors:  C B Chambers; N A Muma
Journal:  Brain Res Mol Brain Res       Date:  1997-08

Review 3.  Towards an understanding of the signal transduction pathways for interleukin 1.

Authors:  L A O'Neill
Journal:  Biochim Biophys Acta       Date:  1995-04-06

Review 4.  The role of interleukin-1 in disease.

Authors:  C A Dinarello; S M Wolff
Journal:  N Engl J Med       Date:  1993-01-14       Impact factor: 91.245

5.  Glial-neuronal interactions in Alzheimer disease: progressive association of IL-1alpha+ microglia and S100beta+ astrocytes with neurofibrillary tangle stages.

Authors:  J G Sheng; R E Mrak; W S Griffin
Journal:  J Neuropathol Exp Neurol       Date:  1997-03       Impact factor: 3.685

Review 6.  Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progression.

Authors:  W S Griffin; J G Sheng; M C Royston; S M Gentleman; J E McKenzie; D I Graham; G W Roberts; R E Mrak
Journal:  Brain Pathol       Date:  1998-01       Impact factor: 6.508

7.  Human olfactory neuroepithelial cells: tyrosine phosphorylation and process extension are increased by the combination of IL-1beta, IL-6, NGF, and bFGF.

Authors:  M P Vawter; J Basaric-Keys; Y Li; D S Lester; R S Lebovics; K P Lesch; H Kulaga; W J Freed; T Sunderland; B Wolozin
Journal:  Exp Neurol       Date:  1996-11       Impact factor: 5.330

8.  Plaque biogenesis in brain aging and Alzheimer's disease. I. Progressive changes in phosphorylation states of paired helical filaments and neurofilaments.

Authors:  J H Su; B J Cummings; C W Cotman
Journal:  Brain Res       Date:  1996-11-11       Impact factor: 3.252

Review 9.  Functions and mechanisms of interleukin 1 in the brain.

Authors:  N J Rothwell
Journal:  Trends Pharmacol Sci       Date:  1991-11       Impact factor: 14.819

10.  Inactivation of a redox-sensitive protein phosphatase during the early events of tumor necrosis factor/interleukin-1 signal transduction.

Authors:  G R Guy; J Cairns; S B Ng; Y H Tan
Journal:  J Biol Chem       Date:  1993-01-25       Impact factor: 5.157

View more
  58 in total

Review 1.  The pervasiveness of interleukin-1 in alzheimer pathogenesis: a role for specific polymorphisms in disease risk.

Authors:  W S Griffin; J A Nicoll; L M Grimaldi; J G Sheng; R E Mrak
Journal:  Exp Gerontol       Date:  2000-07       Impact factor: 4.032

2.  Neuroinflammatory Cytokines-The Common Thread in Alzheimer's Pathogenesis.

Authors:  W Sue T Griffin; Steven W Barger
Journal:  US Neurol       Date:  2010

Review 3.  The role of biomarkers in clinical trials for Alzheimer disease.

Authors:  Leon J Thal; Kejal Kantarci; Eric M Reiman; William E Klunk; Michael W Weiner; Henrik Zetterberg; Douglas Galasko; Domenico Praticò; Sue Griffin; Dale Schenk; Eric Siemers
Journal:  Alzheimer Dis Assoc Disord       Date:  2006 Jan-Mar       Impact factor: 2.703

Review 4.  Innate immune activation in Alzheimer's disease.

Authors:  Ming-Ming Wang; Dan Miao; Xi-Peng Cao; Lin Tan; Lan Tan
Journal:  Ann Transl Med       Date:  2018-05

Review 5.  Neuroinflammation in Alzheimer's disease: chemokines produced by astrocytes and chemokine receptors.

Authors:  Chang Liu; Guohong Cui; Meiping Zhu; Xiangping Kang; Haidong Guo
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01

6.  Effects of Microglial Cytokines on Alzheimer's Disease-Related Phenomena.

Authors:  Yan Ji; Xiaowan Wang; Colin Kalicki; Blaise W Menta; Megan Baumgardner; Scott J Koppel; Ian W Weidling; Judit Perez-Ortiz; Heather M Wilkins; Russell H Swerdlow
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

7.  Association between interleukin-1α C(-889)T polymorphism and Alzheimer's disease: a meta-analysis including 12,817 subjects.

Authors:  Bing-Hu Li; Li-Li Zhang; Yan-Wei Yin; Yan Pi; Lu Guo; Qing-Wu Yang; Chang-Yue Gao; Chuan-Qin Fang; Jing-Zhou Wang; Jing Xiang; Jing-Cheng Li
Journal:  J Neural Transm (Vienna)       Date:  2012-07-28       Impact factor: 3.575

Review 8.  Inflammatory Cytokines and Alzheimer's Disease: A Review from the Perspective of Genetic Polymorphisms.

Authors:  Fan Su; Feng Bai; Zhijun Zhang
Journal:  Neurosci Bull       Date:  2016-08-27       Impact factor: 5.203

9.  IFN-γ promotes τ phosphorylation without affecting mature tangles.

Authors:  Andrew Li; Carolina Ceballos-Diaz; Nadia DiNunno; Yona Levites; Pedro E Cruz; Jada Lewis; Todd E Golde; Paramita Chakrabarty
Journal:  FASEB J       Date:  2015-07-08       Impact factor: 5.191

10.  Sustained interleukin-1β overexpression exacerbates tau pathology despite reduced amyloid burden in an Alzheimer's mouse model.

Authors:  Simantini Ghosh; Michael D Wu; Solomon S Shaftel; Stephanos Kyrkanides; Frank M LaFerla; John A Olschowka; M Kerry O'Banion
Journal:  J Neurosci       Date:  2013-03-13       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.